Metabolism and Nutrition Research group, Louvain Drug Research Institute (LDRI), Walloon Excellence in Life Sciences and BIOtechnology (WELBIO), UCLouvain, Université catholique de Louvain, Av. E. Mounier, 73 B1.73.11, 1200, Brussels, Belgium.
Department of Microbiology and Immunology, Rega Institute for Medical Research, VIB Center for Microbiology, KU Leuven, University of Leuven, Leuven, Belgium.
Microbiome. 2021 Jun 28;9(1):147. doi: 10.1186/s40168-021-01097-8.
Leptin-deficient ob/ob mice and leptin receptor-deficient db/db mice are commonly used mice models mimicking the conditions of obesity and type 2 diabetes development. However, although ob/ob and db/db mice are similarly gaining weight and developing massive obesity, db/db mice are more diabetic than ob/ob mice. It remains still unclear why targeting the same pathway-leptin signaling-leads to the development of two different phenotypes. Given that gut microbes dialogue with the host via different metabolites (e.g., short-chain fatty acids) but also contribute to the regulation of bile acids metabolism, we investigated whether inflammatory markers, bacterial components, bile acids, short-chain fatty acids, and gut microbes could contribute to explain the specific phenotype discriminating the onset of an obese and/or a diabetic state in ob/ob and db/db mice.
Six-week-old ob/ob and db/db mice were followed for 7 weeks; they had comparable body weight, fat mass, and lean mass gain, confirming their severely obese status. However, as expected, the glucose metabolism and the glucose-induced insulin secretion were significantly different between ob/ob and db/db mice. Strikingly, the fat distribution was different, with db/db mice having more subcutaneous and ob/ob mice having more epididymal fat. In addition, liver steatosis was more pronounced in the ob/ob mice than in db/db mice. We also found very distinct inflammatory profiles between ob/ob and db/db mice, with a more pronounced inflammatory tone in the liver for ob/ob mice as compared to a higher inflammatory tone in the (subcutaneous) adipose tissue for db/db mice. When analyzing the gut microbiota composition, we found that the quantity of 19 microbial taxa was in some way affected by the genotype. Furthermore, we also show that serum LPS concentration, hepatic bile acid content, and cecal short-chain fatty acid profiles were differently affected by the two genotypes.
Taken together, our results elucidate potential mechanisms implicated in the development of an obese or a diabetic state in two genetic models characterized by an altered leptin signaling. We propose that these differences could be linked to specific inflammatory tones, serum LPS concentration, bile acid metabolism, short-chain fatty acid profile, and gut microbiota composition. Video abstract.
瘦素缺陷型 ob/ob 小鼠和瘦素受体缺陷型 db/db 小鼠常被用来模拟肥胖和 2 型糖尿病发展的条件的小鼠模型。然而,尽管 ob/ob 和 db/db 小鼠体重增加且肥胖程度相似,但 db/db 小鼠比 ob/ob 小鼠更具糖尿病特征。目前仍不清楚为什么针对相同的途径——瘦素信号——会导致两种不同表型的发展。鉴于肠道微生物通过不同的代谢物(如短链脂肪酸)与宿主进行对话,但也有助于调节胆汁酸代谢,我们研究了炎症标志物、细菌成分、胆汁酸、短链脂肪酸和肠道微生物是否有助于解释区分 ob/ob 和 db/db 小鼠肥胖和/或糖尿病状态的特定表型。
对 6 周龄的 ob/ob 和 db/db 小鼠进行了 7 周的随访;它们的体重、脂肪量和瘦体量增加相当,这证实了它们处于严重肥胖状态。然而,正如预期的那样,ob/ob 和 db/db 小鼠的葡萄糖代谢和葡萄糖诱导的胰岛素分泌存在显著差异。引人注目的是,脂肪分布不同,db/db 小鼠的皮下脂肪较多,ob/ob 小鼠的附睾脂肪较多。此外,ob/ob 小鼠的肝脂肪变性比 db/db 小鼠更明显。我们还发现 ob/ob 和 db/db 小鼠之间存在非常不同的炎症谱,与 db/db 小鼠相比,ob/ob 小鼠的肝脏炎症反应更强烈,而 db/db 小鼠的(皮下)脂肪组织炎症反应更强烈。在分析肠道微生物群落组成时,我们发现 19 种微生物类群的数量在某种程度上受到基因型的影响。此外,我们还表明,血清 LPS 浓度、肝胆汁酸含量和盲肠短链脂肪酸谱受两种基因型的不同影响。
总之,我们的结果阐明了两种遗传模型中肥胖或糖尿病状态发展所涉及的潜在机制,这些模型的特征是瘦素信号改变。我们提出,这些差异可能与特定的炎症反应、血清 LPS 浓度、胆汁酸代谢、短链脂肪酸谱和肠道微生物群落组成有关。